- Home
- PULM vs VBIX Comparison
PULM vs VBIX Comparison
Compare PULM & VBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- VBIX
- Stock Information
- Founded
- PULM 2003
- VBIX N/A
- Country
- PULM United States
- VBIX Israel
- Employees
- PULM N/A
- VBIX N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- VBIX Computer Software: Prepackaged Software
- Sector
- PULM Health Care
- VBIX Technology
- Exchange
- PULM Nasdaq
- VBIX Nasdaq
- Market Cap
- PULM 33.2M
- VBIX 26.4M
- IPO Year
- PULM N/A
- VBIX N/A
- Fundamental
- Price
- PULM $6.55
- VBIX $5.11
- Analyst Decision
- PULM
- VBIX
- Analyst Count
- PULM 0
- VBIX 0
- Target Price
- PULM N/A
- VBIX N/A
- AVG Volume (30 Days)
- PULM 59.3K
- VBIX 127.3K
- Earning Date
- PULM 08-12-2025
- VBIX 08-14-2025
- Dividend Yield
- PULM N/A
- VBIX N/A
- EPS Growth
- PULM N/A
- VBIX N/A
- EPS
- PULM N/A
- VBIX N/A
- Revenue
- PULM $1,921,000.00
- VBIX $19,672,000.00
- Revenue This Year
- PULM N/A
- VBIX N/A
- Revenue Next Year
- PULM $134.88
- VBIX N/A
- P/E Ratio
- PULM N/A
- VBIX N/A
- Revenue Growth
- PULM N/A
- VBIX N/A
- 52 Week Low
- PULM $1.78
- VBIX $0.18
- 52 Week High
- PULM $10.40
- VBIX $12.00
- Technical
- Relative Strength Index (RSI)
- PULM 39.73
- VBIX N/A
- Support Level
- PULM $6.28
- VBIX N/A
- Resistance Level
- PULM $6.96
- VBIX N/A
- Average True Range (ATR)
- PULM 0.44
- VBIX 0.00
- MACD
- PULM -0.08
- VBIX 0.00
- Stochastic Oscillator
- PULM 8.10
- VBIX 0.00
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About VBIX Viewbix Inc. Common Stock
ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.